Abstract
Purpose
The aim of this study was to systematically analyze the clinical characteristics of a large cohort of parasagittal meningioma (PM) and to evaluate the patients’ outcomes and best treatment strategies based on tumor features.
Methods
To minimize selection bias we performed a single-institutional review of PM with restricted criteria. One hundred and ninety-two consecutive patients who met criteria for inclusion were reviewed from 2003 to 2011 in our general hospital.
Results
A total of 131 cases (68.2%) were with WHO grade I, while grade II and grade III PMs constituted 40 (20.8%) and 21 cases (10.9%). Higher histological grade was associated with loss of trimethylation of H3K27 (P = 0.000). For WHO grade I PMs, GTR was significantly associated with a better PFS (P = 0.023); however, adjuvant radiotherapy did not benefit patients with STR (P = 0.215). For de novo high-grade (WHO grade II and III) PMs (n = 37), adjuvant radiotherapy was associated with a significantly longer OS (P = 0.013), while no difference was observed between GTR and STR (P = 0.654). In recurrent high-grade PM patients (n = 24), GTR combined with adjuvant radiotherapy increased PFS (P = 0.005).
Conclusions
This study demonstrated that PMs were a heterogeneous group of tumors with a high proportion of high-grade tumors that often displayed aggressive clinical behaviors. Low-grade PM benefited from radical resection, whereas high-grade de novo PM did not. Adjuvant radiotherapy significantly prolonged OS for high-grade primary PM, but did not impact survival of patients with subtotally resected low-grade tumors. Long-term outcome of high-grade recurrent PMs was dismal. We thus show that extent of tumor resection, tumor grade and tumor recurrent status inform therapeutic decisions for PMs.
Similar content being viewed by others
Abbreviations
- PM:
-
Parasagittal meningioma
- PFS:
-
Progression free survival
- OS:
-
Overall survival
- CNS:
-
Central nervous system
- WHO:
-
World Health Organization
- KPS:
-
Karnofsky performance score
- GTR:
-
Gross total resection
- STR:
-
Subtotal resection
References
Holleczek B, Zampella D, Urbschat S, Sahm F, von Deimling A, Oertel J, Ketter R (2019) Incidence, mortality and outcome of meningiomas: a population-based study from Germany. Cancer Epidemiol 62:101562. https://doi.org/10.1016/j.canep.2019.07.001
Wang DJ, Xie Q, Gong Y, Mao Y, Wang Y, Cheng HX, Zhong P, Che XM, Jiang CC, Huang FP, Zheng K, Li SQ, Gu YX, Bao WM, Yang BJ, Wu JS, Xie LQ, Zheng MZ, Tang HL, Zhu HD, Chen XC, Zhou LF (2013) Histopathological classification and location of consecutively operated meningiomas at a single institution in China from 2001 to 2010. Chin Med J 126:488–493
Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro-Oncology 20:iv1–iv86. https://doi.org/10.1093/neuonc/noy131
Gatterbauer B, Gevsek S, Hoftberger R, Lutgendorf-Caucig C, Ertl A, Mallouhi A, Kitz K, Knosp E, Frischer JM (2017) Multimodal treatment of parasagittal meningiomas: a single-center experience. J Neurosurg 127:1249–1256. https://doi.org/10.3171/2016.9.jns161859
Sindou MP, Alvernia JE (2006) Results of attempted radical tumor removal and venous repair in 100 consecutive meningiomas involving the major dural sinuses. J Neurosurg 105:514–525. https://doi.org/10.3171/jns.2006.105.4.514
Brotchi J (2014) Should we pursue superior sagittal sinus grafting in parasagittal meningiomas in 2013? World Neurosurg 82:325–326. https://doi.org/10.1016/j.wneu.2013.07.107
Mantovani A, Di Maio S, Ferreira MJ, Sekhar LN (2014) Management of meningiomas invading the major dural venous sinuses: operative technique, results, and potential benefit for higher grade tumors. World Neurosurg 82:455–467. https://doi.org/10.1016/j.wneu.2013.06.024
Pettersson-Segerlind J, Orrego A, Lonn S, Mathiesen T (2011) Long-term 25-year follow-up of surgically treated parasagittal meningiomas. World Neurosurg 76:564–571. https://doi.org/10.1016/j.wneu.2011.05.015
Sindou M (2014) Meningiomas involving major dural sinuses: should we attempt at radical removal and venous repair? World Neurosurg 81:46–47. https://doi.org/10.1016/j.wneu.2013.07.119
Byard RW (2017) Parasagittal meningioma: a not so benign entity. Med Sci Law 57:175–178. https://doi.org/10.1177/0025802417732267
Gatterbauer B, Gevsek S, Höftberger R, Lütgendorf-Caucig C, Ertl A, Mallouhi A, Kitz K, Knosp E, Frischer JM (2017) Multimodal treatment of parasagittal meningiomas: a single-center experience. J Neurosurg 127:1249–1256. https://doi.org/10.3171/2016.9.JNS161859
Nowak A, Dziedzic T, Czernicki T, Kunert P, Marchel A (2014) Surgical treatment of parasagittal and falcine meningiomas invading the superior sagittal sinus. Neurol Neurochir Pol 48:174–180. https://doi.org/10.1016/j.pjnns.2014.05.003
Ricci A, Di Vitantonio H, De Paulis D, Del Maestro M, Gallieni M, Dechcordi SR, Marzi S, Galzio RJ (2017) Parasagittal meningiomas: our surgical experience and the reconstruction technique of the superior sagittal sinus. Surg Neurol Int 8:1–1. https://doi.org/10.4103/2152-7806.198728
Katz LM, Hielscher T, Liechty B, Silverman J, Zagzag D, Sen R, Wu P, Golfinos JG, Reuss D, Neidert MC, Wirsching HG, Baumgarten P, Herold-Mende C, Wick W, Harter PN, Weller M, von Deimling A, Snuderl M, Sen C, Sahm F (2018) Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol 135:955–963. https://doi.org/10.1007/s00401-018-1844-9
Hua L, Zhu H, Li J, Tang H, Kuang D, Wang Y, Tang F, Chen X, Zhou L, Xie Q, Gong Y (2018) Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution. J Neurosurg 128:1698–1706. https://doi.org/10.3171/2017.2.jns162566
Zhu H, Bi WL, Aizer A, Hua L, Tian M, Den J, Tang H, Chen H, Wang Y, Mao Y, Dunn IF, Xie Q, Gong Y (2019) Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma. Cancer Med 8:13–20. https://doi.org/10.1002/cam4.1531
Kondziolka D, Patel AD, Kano H, Flickinger JC, Lunsford LD (2016) Long-term outcomes after gamma knife radiosurgery for meningiomas. Am J Clin Oncol 39:453–457. https://doi.org/10.1097/coc.0000000000000080
Hua L, Zhu H, Deng J, Tian M, Jiang X, Tang H, Luan S, Wakimoto H, Xie Q, Gong Y (2018) Clinical and prognostic features of spinal meningioma: a thorough analysis from a single neurosurgical center. J Neuro-Oncol 140:639–647. https://doi.org/10.1007/s11060-018-2993-3
Kim JW, Jung HW, Kim YH, Park CK, Chung HT, Paek SH, Kim DG, Lee SH (2019) Petroclival meningiomas: long-term outcomes of multimodal treatments and management strategies based on 30 years of experience at a single institution. J Neurosurg. https://doi.org/10.3171/2019.2.jns182604
Coroller TP, Bi WL, Huynh E, Abedalthagafi M, Aizer AA, Greenwald NF, Parmar C, Narayan V, Wu WW, Miranda de Moura S, Gupta S, Beroukhim R, Wen PY, Al-Mefty O, Dunn IF, Santagata S, Alexander BM, Huang RY, Aerts H (2017) Radiographic prediction of meningioma grade by semantic and radiomic features. PLoS ONE 12:e0187908. https://doi.org/10.1371/journal.pone.0187908
Zhu Y, Man C, Gong L, Dong D, Yu X, Wang S, Fang M, Wang S, Fang X, Chen X, Tian J (2019) A deep learning radiomics model for preoperative grading in meningioma. Eur J Radiol 116:128–134. https://doi.org/10.1016/j.ejrad.2019.04.022
Colli BO, Carlotti CG Jr, Assirati JA Jr, Dos Santos MB, Neder L, Dos Santos AC (2006) Parasagittal meningiomas: follow-up review. Surg Neurol 66(Suppl 3):S20–S27. https://doi.org/10.1016/j.surneu.2006.08.023; discussion S27–S28
Hess K, Spille DC, Adeli A, Sporns PB, Brokinkel C, Grauer O, Mawrin C, Stummer W, Paulus W, Brokinkel B (2018) Brain invasion and the risk of seizures in patients with meningioma. J Neurosurg 130:789–796. https://doi.org/10.3171/2017.11.jns172265
Mathiesen T, Pettersson-Segerlind J, Kihlstrom L, Ulfarsson E (2014) Meningiomas engaging major venous sinuses. World Neurosurg 81:116–124. https://doi.org/10.1016/j.wneu.2013.01.095
Cho TH, Chung YG, Kim CY, Kim HK, Lee NJ, Chu JW, Choi MS (2000) Intraoperative radiation therapy as an adjunctive therapy for huge and highly vascular parasagittal meningiomas. J Korean Med Sci 15:718–723. https://doi.org/10.3346/jkms.2000.15.6.718
Pinzi V, Fariselli L, Marchetti M, Scorsetti M, Navarria P (2019) Stereotactic radiotherapy for parasagittal and parafalcine meningiomas: patient selection and special considerations. Cancer Manag Res 11:10051–10060. https://doi.org/10.2147/CMAR.S187371
Sasayama T, Nishihara M, Tanaka K, Mizukawa K, Ehara K, Kanomata N, Kohmura E (2008) Two metachronous tumors induced by radiation therapy: case report and review of the literature. J Neurooncol 88:315–320. https://doi.org/10.1007/s11060-008-9570-0
Shen H, Yu M, Tsoli M, Chang C, Joshi S, Liu J, Ryall S, Chornenkyy Y, Siddaway R, Hawkins C, Ziegler DS (2019) Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas. Neuro Oncol. https://doi.org/10.1093/neuonc/noz140
Boskos C, Feuvret L, Noel G, Habrand JL, Pommier P, Alapetite C, Mammar H, Ferrand R, Boisserie G, Mazeron JJ (2009) Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys 75:399–406. https://doi.org/10.1016/j.ijrobp.2008.10.053
Girvigian MR, Chen JC, Rahimian J, Miller MJ, Tome M (2008) Comparison of early complications for patients with convexity and parasagittal meningiomas treated with either stereotactic radiosurgery or fractionated stereotactic radiotherapy. Neurosurgery 62:A19–A27. https://doi.org/10.1227/01.neu.0000325933.34154.cb; discussion A18–A27
Magill ST, Theodosopoulos PV, McDermott MW (2016) Resection of falx and parasagittal meningioma: complication avoidance. J Neurooncol 130:253–262. https://doi.org/10.1007/s11060-016-2283-x
Aizer AA, Arvold ND, Catalano P, Claus EB, Golby AJ, Johnson MD, Al-Mefty O, Wen PY, Reardon DA, Lee EQ, Nayak L, Rinne ML, Beroukhim R, Weiss SE, Ramkissoon SH, Abedalthagafi M, Santagata S, Dunn IF, Alexander BM (2014) Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro-Oncology 16:1547–1553. https://doi.org/10.1093/neuonc/nou098
Choi Y, Lim DH, Jo K, Nam D-H, Seol HJ, Lee J-I (2014) Efficacy of postoperative radiotherapy for high grade meningiomas. J Neurooncol 119:405–412. https://doi.org/10.1007/s11060-014-1507-1
Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamaridès M, Menei P, Deruty R, Moreau JJ, Fèvre-Montange M, Guyotat J (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367–375. https://doi.org/10.1007/s11060-009-9934-0
Valery CA, Faillot M, Lamproglou I, Golmard JL, Jenny C, Peyre M, Mokhtari K, Mazeron JJ, Cornu P, Kalamarides M (2016) Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm. J Neurosurg 125:89–96. https://doi.org/10.3171/2016.7.gks161521
Wang C, Kaprealian TB, Suh JH, Kubicky CD, Ciporen JN, Chen Y, Jaboin JJ (2017) Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma. Neuro-Oncology 19:1263–1270. https://doi.org/10.1093/neuonc/nox007
Weber DC, Ares C, Villa S, Peerdeman SM, Renard L, Baumert BG, Lucas A, Veninga T, Pica A, Jefferies S, Ricardi U, Miralbell R, Stelmes JJ, Liu Y, Collette L, Collette S (2018) Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase-II parallel non-randomized and observation study (EORTC 22042–26042). Radiother Oncol. https://doi.org/10.1016/j.radonc.2018.06.018
Jamilson Araújo Pereira B, Nogueira de Almeida A, Pires H, de Aguiar P, Silva Paiva W, Jacobsen Teixeira M, Kazue Nagahashi Marie S (2019) Comprehensive analysis of meningioma in the first two decades of life: a systematic review. Neurochirurgie. https://doi.org/10.1016/j.neuchi.2019.10.007
Acknowledgements
This study was supported by grants from the National Key R&D Program of China (2018YFC1312600, 2018YFC1312604 to Y. Gong), National Natural Science Foundation of China (81772674 to Y. Gong) and the Science and Technology Commission of Shanghai Municipality (18140900200 to Y. Gong).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors had no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
11060_2020_3440_MOESM1_ESM.tif
Supplementary Fig. 1 Examples of meningiomas positive and negative for H3K27me3 staining. A, B & C, Coronal, sagittal and axial enhanced MR scanning of a 55-year-old female patient with a recurrent atypical meningioma showing negative of H3K27me3 staining. D, E & F, H&E, Ki-67 and H3K27me3 staining; G, H & I, Coronal, sagittal and axial enhanced MR scanning of a 42-year-old male patient with a de-novo meningethelial meningioma showing positive of H3K27me3 staining. J, K & L, H&E, Ki-67 and H3K27me3 staining. (TIF 1626 kb)
Rights and permissions
About this article
Cite this article
Hua, L., Wang, D., Zhu, H. et al. Long-term outcomes of multimodality management for parasagittal meningiomas. J Neurooncol 147, 441–450 (2020). https://doi.org/10.1007/s11060-020-03440-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-020-03440-9